Skip to Content

Evaluation of the Minority AIDS Initiative (MAI) for High Risk Men of New Jersey

 

Racial minority men are at high risk for infectious diseases, which may present particular challenges for men with substance use disorders. However, few men receive coordinated treatment for substance use and infectious diseases, and even fewer receive concurrent services for mental health disorders and other psychosocial hardships. To address these issues, a collaboration between the Rowan University School of Medicine (project director), Rutgers Center for Prevention Science (evaluator), and Maryville Addiction Treatment Center (implementation site) was awarded the Minority Aids Initiative (MAI) for High Risk Men of New Jersey through a $2.5 million federal grant from SAMHSA in 2019.

The evaluation of the Minority AIDS Initiative is led by Dr. Jamey Lister (PI), alongside the Director and Associate Director from the Center for Prevention Science, Dr. Andrew Peterson (Co-PI) and Dr. Kristen Gilmore Powell (Co-I). The evaluation, through a $500,000 sub-award, will examine whether the initiative improves service coordination for infectious diseases, co-occurring psychiatric disorders, and recovery coaching among African American and Hispanic men in treatment for substance use. The evaluators will investigate program and client factors that predict performance and treatment outcomes using consumer interview data they manage at multiple time points, as well as help develop data collection tools and study design strategies.

Back to top